{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:57:16Z","timestamp":1793066236186,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.msard.2023.104513","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T02:39:06Z","timestamp":1673318346000},"page":"104513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod"],"prefix":"10.1016","volume":"70","author":[{"given":"Eizo","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-4254","authenticated-orcid":false,"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104513_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.410330309","article-title":"A population-based study of multiple sclerosis in twins: update","volume":"33","author":"Sadovnick","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101872","article-title":"Environmental risk factors for multiple sclerosis in Japanese people","volume":"38","author":"Sakoda","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104513_bib0004","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/awh471","article-title":"Cigarette smoking and the progression of multiple sclerosis","volume":"128","author":"Hern\u00e1n","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104513_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.msard.2017.07.020","article-title":"Smoking and multiple sclerosis: a systematic review and meta-analysis using the Bradford Hill criteria for causation","volume":"17","author":"Degelman","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104513_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103115","article-title":"Early predictors of conversion to secondary progressive multiple sclerosis","volume":"54","author":"Barzegar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104513_bib0007","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1212\/NXI.0000000000000260","article-title":"No association of tobacco use and disease activity in multiple sclerosis","volume":"3","author":"Kvistad","year":"2016","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.msard.2023.104513_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102773","article-title":"The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis","volume":"49","author":"Messina","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104513_bib0009","article-title":"Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod","volume":"6","author":"Hersh","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2023.104513_bib0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0011","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104513_bib0012","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104513_bib0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40120-019-00160-9","article-title":"Fingolimod rebound: a review of the clinical experience and management considerations","volume":"8","author":"Barry","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2023.104513_bib0014","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1352458515616701","article-title":"Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019 (NEDA-4) in relapsing-remitting multiple sclerosis","volume":"22","author":"Kappos","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104513_bib0015","doi-asserted-by":"crossref","first-page":"e16149","DOI":"10.1371\/journal.pone.0016149","article-title":"Smoking and multiple sclerosis: an updated meta- analysis","volume":"6","author":"Handel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2023.104513_bib0016","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneurol.2009.122","article-title":"Smoking and disease progression in multiple sclerosis","volume":"66","author":"Healy","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2015.03.006","article-title":"Smoking worsens multiple sclerosis prognosis: two different pathways are involved","volume":"281","author":"Correale","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104513_bib0018","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.msard.2023.104513_bib0019","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.msard.2023.104513_bib0020","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/01.WNL.0000142043.32578.5D","article-title":"CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis","volume":"63","author":"Rejdak","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104513_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101873","article-title":"Glutamate and Nitric Oxide as biomarkers for disease activity in patients with multiple sclerosis","volume":"38","author":"abdel Naseer","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104513_bib0022","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.24217","article-title":"Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide","volume":"76","author":"Colombo","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0023","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1212\/WNL.0000000000004949","article-title":"Smoking affects the interferon beta treatment response in multiple sclerosis","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104513_bib0024","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/1352458518791753","article-title":"Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis","volume":"25","author":"Petersen","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104513_bib0025","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00415-010-5606-4","article-title":"Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta","volume":"257","author":"Sena","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0026","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1352458513498635","article-title":"Smoking and risk of treatment-induced neutralizing antibodies to interferon \u03b2-1a","volume":"20","author":"Hedstr\u00f6m","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104513_bib0027","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/1352458513515086","article-title":"Smokers run increased risk of developing anti-natalizumab antibodies","volume":"20","author":"Hedstr\u00f6m","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104513_bib0028","doi-asserted-by":"crossref","first-page":"e48592","DOI":"10.1371\/journal.pone.0048592","article-title":"Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients","volume":"7","author":"Yoshimura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2023.104513_bib0029","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00415-015-7637-3","article-title":"Multiple sclerosis in Japan appears to be a milder disease compared to the UK","volume":"262","author":"Piccolo","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104513_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2009.01.008","article-title":"Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey","volume":"280","author":"Ishizu","year":"2009","journal-title":"J. Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:05:19Z","timestamp":1761901519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"alternative-id":["S2211034823000172"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104513","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of smoking on disease activity in multiple sclerosis patients treated with dimethyl fumarate or fingolimod","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104513"}}